The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,936
Sort by:
The 2027-2032 World Outlook for Influenza Medications
US$ 1,195.00
This study covers the world outlook for influenza medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Inhalable Drugs
US$ 1,195.00
This study covers the world outlook for inhalable drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Inhaled Nitric Oxides
US$ 1,195.00
This study covers the world outlook for inhaled nitric oxides across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Injectable Diabetes Drugs
US$ 1,195.00
This study covers the world outlook for injectable diabetes drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Insomnia
US$ 1,195.00
This study covers the world outlook for insomnia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the cou...
January 2026
287 pages
The 2027-2032 World Outlook for Insomnia Drugs
US$ 1,195.00
This study covers the world outlook for insomnia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Insomnia Therapeutics
US$ 1,195.00
This study covers the world outlook for insomnia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Interleukin Inhibitors
US$ 1,195.00
This study covers the world outlook for interleukin inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Intravenous Immunoglobulins
US$ 1,195.00
This study covers the world outlook for intravenous immunoglobulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Iron Deficiency Anemia Drugs
US$ 1,195.00
This study covers the world outlook for iron deficiency anemia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Iron Drugs
US$ 1,195.00
This study covers the world outlook for iron drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the c...
January 2026
287 pages
The 2027-2032 World Outlook for Joint Pain Injections
US$ 1,195.00
This study covers the world outlook for joint pain injections across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Kidney Cancer Drugs
US$ 1,195.00
This study covers the world outlook for kidney cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Kinase Inhibitors
US$ 1,195.00
This study covers the world outlook for kinase inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Krabbe Disease Treatments
US$ 1,195.00
This study covers the world outlook for Krabbe disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Laxatives
US$ 1,195.00
This study covers the world outlook for laxatives across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co...
January 2026
287 pages
The 2027-2032 World Outlook for Leukemia Treatments
US$ 1,195.00
This study covers the world outlook for leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Lifestyle Drugs
US$ 1,195.00
This study covers the world outlook for lifestyle drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Liothyronine
US$ 1,195.00
This study covers the world outlook for liothyronine across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Lipid Disorder Treatments
US$ 1,195.00
This study covers the world outlook for lipid disorder treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Lipopeptide MRSA Drugs
US$ 1,195.00
This study covers the world outlook for lipopeptide MRSA drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Liposomal Doxorubicin
US$ 1,195.00
This study covers the world outlook for liposomal doxorubicin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Liver Cirrhosis Drugs
US$ 1,195.00
This study covers the world outlook for liver cirrhosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Local Anesthesia Drugs
US$ 1,195.00
This study covers the world outlook for local anesthesia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Lupus Drugs
US$ 1,195.00
This study covers the world outlook for lupus drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Lupus Therapeutics
US$ 1,195.00
This study covers the world outlook for lupus therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Lymphoma Treatments
US$ 1,195.00
This study covers the world outlook for lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Lyophilized Injectable Drugs
US$ 1,195.00
This study covers the world outlook for lyophilized injectable drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Lysosomal Disease Treatments
US$ 1,195.00
This study covers the world outlook for lysosomal disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Lysosomal Storage Diseases
US$ 1,195.00
This study covers the world outlook for lysosomal storage diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
287 pages
The 2027-2032 World Outlook for Macrolide Antibiotics
US$ 1,195.00
This study covers the world outlook for macrolide antibiotics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Macrolide Drugs
US$ 1,195.00
This study covers the world outlook for macrolide drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Male Hypogonadism
US$ 1,195.00
This study covers the world outlook for male hypogonadism across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Medical Morphine
US$ 1,195.00
This study covers the world outlook for medical morphine across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Medication Adherence
US$ 1,195.00
This study covers the world outlook for medication adherence across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
